LIPOLYSIS EXPOSES UNREACTIVE ENDOGENOUS APOLIPOPROTEIN-E-3 IN HUMAN AND RAT PLASMA VERY LOW-DENSITY-LIPOPROTEIN

被引:56
作者
SEHAYEK, E [1 ]
LEWINVELVERT, U [1 ]
CHAJEKSHAUL, T [1 ]
EISENBERG, S [1 ]
机构
[1] HADASSAH UNIV HOSP, DEPT MED B, LIPID RES LAB, IL-91120 JERUSALEM, ISRAEL
关键词
VLDL REMNANTS; LDL RECEPTOR; TRIGLYCERIDE TRANSPORT; APOLIPOPROTEIN-B-100; LIPOPROTEIN LIPASE;
D O I
10.1172/JCI115339
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Endogenous apolipoprotein E in VLDL is poorly expressed in receptor binding processes. Yet catabolism of VLDL-remnants by cellular receptors depends on functional apo E molecules. To better understand remnant catabolism phenomena, we determined the metabolism of VLDL and post-lipolysis VLDL by cultured cells. Partial lipolysis was achieved by incubation of VLDL with lipoprotein lipase in vitro (human) or recirculation (rat) in supradiaphragmatic animals. Lipolyzed VLDL exhibit metabolic activities 2-20-fold higher than control VLDL, that are saturable and dependent on the presence of LDL receptors. The ligand responsible for receptor interaction of lipolyzed VLDL (apo E or apo B-100) and its source (endogenous or transferred) was studied with monoclonal antibodies and with lipoproteins from E-3/3 and E-2/2 subjects. The data unequivocally proved that lipolysis causes exposure of unreactive endogenous apo E-3 at the VLDL surface, possibly by a change of conformation of the protein. Apo B-100 becomes biologically expressed only in lipolyzed VLDL-III. Lipolyzed VLDL, however, is less reactive to exogenous apo E-3 than control VLDL indicating that endogenous and exogenous apo E are oriented differently in VLDL. It is proposed that VLDL delivers triglycerides to tissues when apo E is unreactive but becomes a remnant after the protein becomes exposed and directs the particles from lipoprotein lipase sites to cellular receptors.
引用
收藏
页码:553 / 560
页数:8
相关论文
共 35 条
[1]   A TECHNIQUE FOR PREPARATION OF FUNCTIONAL SUPRADIAPHRAGMATIC PORTION OF RAT [J].
BEZMANTARCHER, A ;
ROBINSON, DS .
PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1965, 162 (988) :406-+
[2]   VERY LOW-DENSITY LIPOPROTEIN REMNANT PARTICLES - UPTAKE BY AORTIC SMOOTH-MUSCLE CELLS IN CULTURE [J].
BIERMAN, EL ;
EISENBERG, S ;
STEIN, O ;
STEIN, Y .
BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 329 (01) :163-169
[3]   METABOLISM OF VERY LOW-DENSITY LIPOPROTEIN PROTEINS .1. PRELIMINARY IN-VITRO AND IN-VIVO OBSERVATIONS [J].
BILHEIMER, DW ;
LEVY, RI ;
EISENBERG, S .
BIOCHIMICA ET BIOPHYSICA ACTA, 1972, 260 (02) :212-+
[4]   A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
SCIENCE, 1986, 232 (4746) :34-47
[5]   VERY LOW-DENSITY LIPOPROTEIN - METABOLISM OF PHOSPHOLIPIDS, CHOLESTEROL, AND APOLIPOPROTEIN-C IN ISOLATED PERFUSED RAT-HEART [J].
CHAJEK, T ;
EISENBERG, S .
JOURNAL OF CLINICAL INVESTIGATION, 1978, 61 (06) :1654-1665
[6]   METABOLISM OF RAT PLASMA VERY LOW-DENSITY LIPOPROTEIN .2. FATE IN CIRCULATION OF APOPROTEIN SUBUNITS [J].
EISENBERG, S ;
RACHMILEWITZ, D .
BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 326 (03) :391-405
[7]   ENHANCED METABOLISM OF NORMOLIPIDEMIC HUMAN-PLASMA VERY LOW-DENSITY LIPOPROTEIN IN CULTURED-CELLS BY EXOGENOUS APOLIPOPROTEIN-E-3 [J].
EISENBERG, S ;
FRIEDMAN, G ;
VOGEL, T .
ARTERIOSCLEROSIS, 1988, 8 (05) :480-487
[8]  
EISENBERG S, 1976, LOW DENSITY LIPOPROT, P73
[9]   CELLULAR-METABOLISM OF HUMAN PLASMA INTERMEDIATE-DENSITY LIPOPROTEIN (IDL) [J].
FRIEDMAN, G ;
GAVISH, D ;
VOGEL, T ;
EISENBERG, S .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1044 (01) :118-126
[10]   CONTROL OF 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE-ACTIVITY IN CULTURED HUMAN FIBROBLASTS BY VERY LOW-DENSITY LIPOPROTEINS OF SUBJECTS WITH HYPERTRIGLYCERIDEMIA [J].
GIANTURCO, SH ;
GOTTO, AM ;
JACKSON, RL ;
PATSCH, JR ;
SYBERS, HD ;
TAUNTON, OD ;
YESHURUN, DL ;
SMITH, LC .
JOURNAL OF CLINICAL INVESTIGATION, 1978, 61 (02) :320-328